You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

~ Buy the SILICON DIOXIDE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Drugs Containing Excipient (Inactive Ingredient) SILICON DIOXIDE

✉ Email this page to a colleague

« Back to Dashboard

Branded drugs containing SILICON DIOXIDE excipient, and estimated key patent expiration / generic entry dates

Company Tradename Ingredient NDC Excipient Potential Generic Entry
Eli Lilly and Company RETEVMO selpercatinib 0002-3977 SILICON DIOXIDE 2038-10-10
Eli Lilly and Company VERZENIO abemaciclib 0002-4483 SILICON DIOXIDE 2029-12-15
Eli Lilly and Company JAYPIRCA pirtobrutinib 0002-6902 SILICON DIOXIDE 2030-12-01
ER Squibb & Sons LLC SOTYKTU deucravacitinib 0003-0895 SILICON DIOXIDE 2027-09-09
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.